Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.365 USD | -1.46% | -0.98% | -60.87% |
May. 01 | Minerva Neurosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Feb. 27 | Sector Update: Health Care Stocks Ease Late Afternoon | MT |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 16.78M |
---|---|---|---|---|---|
Net income 2024 * | -12M | Net income 2025 * | -54M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.67
x | P/E ratio 2025 * |
-0.53
x | Employees | 9 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 77.74% |
Latest transcript on Minerva Neurosciences, Inc.
1 day | +0.26% | ||
1 week | -0.98% | ||
Current month | +1.96% | ||
1 month | -4.33% | ||
3 months | -74.51% | ||
6 months | -55.28% | ||
Current year | -60.87% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 63 | 14-02-28 | |
Geoff Race
FOU | Founder | 63 | 10-06-30 |
Fred Ahlholm
DFI | Director of Finance/CFO | 58 | 13-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jeryl Hilleman
BRD | Director/Board Member | 66 | 18-07-16 |
Jan van Heek
BRD | Director/Board Member | 75 | 14-06-30 |
Director/Board Member | 68 | 17-12-09 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-02 | 2.406 | +0.26% | 6 681 |
24-05-01 | 2.4 | +1.70% | 15,793 |
24-04-30 | 2.36 | -2.08% | 19,462 |
24-04-29 | 2.41 | -1.09% | 11,451 |
24-04-26 | 2.436 | +0.27% | 4,167 |
Delayed Quote Nasdaq, May 02, 2024 at 03:27 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-60.87% | 16.78M | |
-1.69% | 104B | |
+6.81% | 97.47B | |
+5.71% | 22.25B | |
-12.70% | 21.68B | |
-9.70% | 18.2B | |
-39.98% | 17.02B | |
-10.25% | 16.36B | |
+7.01% | 14.39B | |
+37.42% | 12.37B |
- Stock Market
- Equities
- NERV Stock